ArticleAnnals of the rheumatic diseases2019

Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series.

Javier Narváez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.